Related Experiment Video
Updated: Aug 31, 2025

08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
Where does SARS-CoV-2 go to in man?†.
1Department of Cellular Pathology, St Thomas' Hospital, London, UK.
The Journal of Pathology
|August 25, 2022
Summary
The SARS-CoV-2 virus infects human cells by binding to the ACE2 receptor. This study identified ACE2-expressing cells in various organs, including endothelial cells and the gut, expanding our understanding of COVID-19 pathogenesis.
Area of Science:
- Pathology
- Virology
- Cell Biology
Background:
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 by targeting the angiotensin-converting enzyme 2 (ACE2) receptor.
- The respiratory tract is a primary site of infection, but the full range of susceptible cells across human organs remains under investigation.
Purpose of the Study:
- To comprehensively identify human cells and tissues susceptible to SARS-CoV-2 infection.
- To investigate the distribution of the ACE2 receptor and viral presence in various organs beyond the respiratory system.
Main Methods:
- Analysis of autopsy-derived human tissues.
- Detection of SARS-CoV-2 RNA and ACE2 expression in diverse cell types.
Main Results:
- SARS-CoV-2, associated with ACE2, was detected in endothelial cells, renal and biliary epithelium, megakaryocytes, hepatocytes, and gut myenteric plexus cells.
- The virus was notably absent in heart myofibres and brain neurones.
- Infection susceptibility was confirmed across the respiratory epithelium from the nose to the alveoli.
Conclusions:
- This study confirms and expands the known cellular tropism of SARS-CoV-2 in humans.
- The widespread presence of ACE2 and viral RNA in endothelial cells and other organs highlights potential mechanisms for systemic COVID-19 pathology.
- Findings support further research into the pathogenesis of COVID-19 in various organ systems.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
15.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Viral Recombination
23.7K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.7K
Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K

